BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23352270)

  • 1. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
    Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
    Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
    Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
    Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hyperglycemia on neuropathological alterations during critical illness.
    Sonneville R; den Hertog HM; Güiza F; Gunst J; Derese I; Wouters PJ; Brouland JP; Polito A; Gray F; Chrétien F; Charlier P; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2113-23. PubMed ID: 22442271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice.
    Sonneville R; Derese I; Marques MB; Langouche L; Derde S; Chatre L; Chrétien F; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
    Shock; 2015 Sep; 44(3):245-51. PubMed ID: 26009823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
    Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.
    Vanhorebeek I; Ellger B; De Vos R; Boussemaere M; Debaveye Y; Perre SV; Rabbani N; Thornalley PJ; Van den Berghe G
    Crit Care Med; 2009 Apr; 37(4):1355-64. PubMed ID: 19242345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits.
    Derde S; Vanhorebeek I; Güiza F; Derese I; Gunst J; Fahrenkrog B; Martinet W; Vervenne H; Ververs EJ; Larsson L; Van den Berghe G
    Endocrinology; 2012 May; 153(5):2267-76. PubMed ID: 22396453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemic kidney damage in an animal model of prolonged critical illness.
    Vanhorebeek I; Gunst J; Ellger B; Boussemaere M; Lerut E; Debaveye Y; Rabbani N; Thornalley PJ; Schetz M; Van den Berghe G
    Kidney Int; 2009 Sep; 76(5):512-20. PubMed ID: 19536085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted glucose regulation during rapid step-wise increases of parenteral nutrition in critically ill patients: a proof of concept study.
    Hoekstra M; Schoorl MA; van der Horst IC; Vogelzang M; Wietasch JK; Zijlstra F; Nijsten MW
    JPEN J Parenter Enteral Nutr; 2010; 34(5):549-53. PubMed ID: 20852185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
    Langouche L; Mesotten D; Vanhorebeek I
    Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of hyperglycemia in non critically-ill patients receiving parenteral nutrition: incidence and risk factors.
    Llop JM; Leiva E; Mateu-de Antonio J; Berlana D; Badia M; Casasín T; Miana M; Pons M; Maroto M; Chicharro L; López-Suñé E; Díaz-Munio E; Sevilla D; Martínez I; Vitales M; Casajuana MT; Bobis MA
    Nutr Hosp; 2012; 27(5):1521-6. PubMed ID: 23478700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute glycemic control in critically ill perioperative patients; the impact of parenteral nutrition on the effect of intensive insulin therapy].
    Egi M
    Masui; 2012 May; 61(5):465-70. PubMed ID: 22702088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current recommended parenteral protein intakes do not support protein synthesis in critically ill septic, insulin-resistant adolescents with tight glucose control.
    Verbruggen SC; Coss-Bu J; Wu M; Schierbeek H; Joosten KF; Dhar A; van Goudoever JB; Castillo L
    Crit Care Med; 2011 Nov; 39(11):2518-25. PubMed ID: 21765361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
    Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
    Weekers F; Giulietti AP; Michalaki M; Coopmans W; Van Herck E; Mathieu C; Van den Berghe G
    Endocrinology; 2003 Dec; 144(12):5329-38. PubMed ID: 12960028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and insulin administration while maintaining normoglycemia: the GIN concept.
    Carvalho G; Lattermann R; Codere-Maruyama T; Schricker T
    Minerva Anestesiol; 2013 Jan; 79(1):74-82. PubMed ID: 23032923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of intensive insulin therapy in critically ill patients.
    Whyte MB; Jackson NC; Shojaee-Moradie F; Treacher DF; Beale RJ; Jones RH; Umpleby AM
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E697-705. PubMed ID: 20028969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.